Company intelligence / Profile preview

Hura Imaging

Los Angeles, California, United Stateshuraimaging.com ↗

Ownership: Private
Development stage: Commercial

Overview

Hura Imaging develops and commercializes advanced AI-powered software for medical imaging, aiming to improve safety by reducing radiation/contrast agent use, enhance diagnostic accuracy and efficiency for treatment planning, lower costs, and increase regulatory compliance. The company has received NIH STTR/SBIR grants for its innovations. It collaborates with major OEMs such as Philips, Siemens, Samsung, and Neusoft. Recent funding was secured from Device of Tomorrow Capital in January 2025.

Therapeutic areas: OtherNeurology
Modalities: DeviceSoftware (AI-based medical imaging)
Industry: Medical Imaging

Drug pipeline

1 asset

HuraASL

Pre-clinical

Indications: Neurological disorders

Partnerships

Collaborations with large OEMs including Philips, Siemens, Samsung, Neusoft

Beyond the preview

Go deeper on Hura Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hura Imaging.

Explore the full profile